<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="11373">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02958878</url>
  </required_header>
  <id_info>
    <org_study_id>GenesysRMC</org_study_id>
    <nct_id>NCT02958878</nct_id>
  </id_info>
  <brief_title>Preoperative Administration of Tamsulosin for Prevention of Post Operative Urinary Retention in Males Undergoing Elective Inguinal Hernia Repair</brief_title>
  <official_title>Preoperative Administration of Tamsulosin for Prevention of Post Operative Urinary Retention in Males Undergoing Elective Inguinal Hernia Repair</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Genesys Regional Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Genesys Regional Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Double blinded, randomized controlled prospective study looking at 2 preoperative doses of
      Tamsulosin an alpha-adrenergic blocker in preventing post-operative urinary retention. A
      previous study was conducted called &quot;Effectiveness of tamsulosin inprevention of
      postoperative urinary retention: a randomized double-blind-placebo controlled study&quot; This
      study involved a tertiary care center involving mostly urological surgical procedures. We
      look to specifically look at inguinal hernia surgeries in males. The aim of this study is to
      compare the prophylactic effect of tamsulosin with placebo on postoperative urinary
      retention. The drug is FDA approved for benign prostatic hypertrophy and urinary retention.
      It is on formulary at Genesys. Currently there is no standard procedure of prophylactic
      tamsulosin for urinary retention. Most often post operative patients are given tamsulosin to
      augment smooth muscle relaxation and spontaneous voiding if the patient is having urinary
      retention post operatively. We often straight catheterize patients once and start tamsulosin
      with the goal of avoiding urinary retention and future straight catheterizations or
      placement of foley catheters
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>December 2016</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double Blind (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>number of Urinary Retention</measure>
    <time_frame>within 72 hours of surgery</time_frame>
    <description>If patients have urinary retention post operatively</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>placebo vs tamsulosin</measure>
    <time_frame>within 72 hours of surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Postoperative Urinary Retention</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Tamsulosin 0.4mg given the night before surgery and another dose the day of surgery in the morning.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo medication given the night before surgery and another dose the day of surgery in the morning</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tamsulosin</intervention_name>
    <arm_group_label>A</arm_group_label>
    <other_name>Flomax</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo Oral Capsule</intervention_name>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy males, who are not taking Tamsulosin regularly who are undergoing elective
             inguinal hernia repair (laparoscopic, open, and robotic assisted)

        Exclusion Criteria:

          -  Patients who are already taking tamsulosin, terazosin (alpha blocker treatement for
             BPH) , finasteride, dutasteride ( both 5 alpha reductase inhibitors), sulfa allergy,
             and lactose allergy
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>November 2016</verification_date>
  <lastchanged_date>November 7, 2016</lastchanged_date>
  <firstreceived_date>November 5, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Genesys Regional Medical Center</investigator_affiliation>
    <investigator_full_name>Anthony Tabatabai</investigator_full_name>
    <investigator_title>General Surgery Resident</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hernia, Inguinal</mesh_term>
    <mesh_term>Urinary Retention</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Tamsulosin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
